Business Wire

CA-BLUEBEAM-SOFTWARE

Del
Skanska and Bluebeam Software Enter Global Purchasing Agreement

Bluebeam Revu for PDF-based collaboration now available to Skanska project teams around the world

Skanska , one of the world’s largest international project development and construction groups, has entered into a global purchasing agreement with Bluebeam® Software , the leading developer of PDF-based solutions for digital project workflows. Under this new agreement, Skanska project teams throughout the world can deploy Bluebeam’s flagship solution, Revu ® , for digital project communication and collaboration. This decision comes after the successful implementation of Revu by numerous Skanska project teams in Sweden and the US, including the firm’s largest project to date – the 14 billion SEK New Karolinska (NKS) University Hospital in Stockholm, Sweden.

Bluebeam Revu is a PDF-based solution that enables architecture, engineering and construction professionals to streamline workflows, improve communication and reduce paper use. Revu includes 2D and 3D PDF creation and a variety of industry-standard redlining tools including text, highlights, shapes, clouds, CAD symbols and measurements. Advanced features include automatic drawing comparisons, hyperlink management, integration with SharePoint® and ProjectWise® , and tablet PC compatibility. Additionally, Revu includes an integrated cloud solution, Bluebeam Studio™ , for storing PDFs and other project files online and collaborating in real-time on PDFs.

Skanska’s NKS project team is currently using several of these features to electronically share information for this massive, 320,000 gross square metres facility. Project team members are using Revu to create and annotate PDFs, enabling them to easily share detailed drawings, comments and questions with project team members downstream. The team is also organizing and managing the enormous amount of project information by using Links – Revu’s hyperlink manager – to link PDF drawings to additional project data stored in SharePoint® .

“Revu is a powerful solution that creates so many opportunities for streamlining project communication and collaboration and allows project teams to work more efficiently,” said Christian Gren, Director of Account Services, Bluebeam AB. “With this agreement, Skanska project teams can increase productivity, create significant time savings and reduce costs, ultimately having a substantial impact on the bottom line.”

“Skanska’s implementation of Revu on the incredible New Karolinska Solna project proves that anything is possible with Bluebeam,” said Kristine Hopkins, Bluebeam Software’s Director of Account Services. “Bluebeam is thrilled to enter into this purchasing agreement with Skanska, making it easier for its project teams around the globe to communicate and collaborate digitally and work without limits.”

Bluebeam Software products are available direct and through a global network of authorized resellers. For more information, visit www.bluebeam.com .

About Skanska

Skanska is one of the world’s leading project development and construction groups, with expertise in construction, development of commercial and residential projects as well as public-private partnerships. It creates sustainable solutions and aims to be a leader in quality, green construction, work safety and business ethics. For more information, visit www.skanska.com .

About Bluebeam Software, Inc.

Not your typical software company, Bluebeam Software makes smart, simple collaboration solutions for paperless workflows based on the PDF format. Founded in 2002 in Pasadena, California, Bluebeam's award-winning PDF creation, markup and collaboration solutions are used today by the world's top architectural, engineering and construction firms, oil and gas companies, as well as government agencies, accountants and even attorneys, as an intuitive, easy-to-use, PDF-based software solution for dramatically improved workflow and more sustainable, paperless operations. Bluebeam supports customers in more than 65 countries directly through its Account Services team in addition to an extensive reseller network. For more information, visit www.bluebeam.com .

About Bluebeam AB

Bluebeam AB is an independently owned and operated software consulting firm exclusively focused on distributing Bluebeam Software products and supporting customers and partners in the Nordics. The firm partnered with Bluebeam in 2010, following five years of influencing and supporting the adoption of Bluebeam products among the growing number of European CAD users, manufacturing and AEC firms looking to digitize project workflows. For more information call +46 841.020.530.

Contact:

Bluebeam Software, Inc.
Kyle Loomis
626-229-8600
kloomis@bluebeam.com

Link:

ClickThru

Information om Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Følg pressemeddelelser fra Business Wire

Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.

Flere pressemeddelelser fra Business Wire

Fujirebio Receives Marketing Clearance for Lumipulse®G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-vitro Diagnostic Test as an Aid to Identify Patients With Amyloid Pathology Associated With Alzheimer’s Disease17.5.2025 08:58:00 CEST | Press release

—First Blood-Based In-Vitro Diagnostic Test to Receive FDA Clearancefor Patients Being Assessed for Alzheimer’s Disease. ——Availability of Accurate, Accessible, Blood-Based Diagnostic Tests Will Aid in Development and Availability of More Effective Interventions for Alzheimer’s Disease — Fujirebio today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s Lumipulse® G pTau 217/β-Amyloid 1-42 Plasma Ratio in-vitro diagnostic (IVD) test for the assessment of amyloid pathology in patients being evaluated for Alzheimer’s disease and other causes of cognitive decline. The test, which was granted Breakthrough Device Designation by the FDA, is the first FDA cleared blood-based IVD test in the U.S. to aid to identify patients with amyloid pathology associated with Alzheimer’s Disease (AD). Alzheimer’s disease currently affects an estimated 7.2 million Americans, a number projected to rise to nearly 14 million by 2060.1 It is a leading cause

IFF Announces Pricing of Tender Offers For Certain Outstanding Series of Notes16.5.2025 23:17:00 CEST | Press release

IFF (NYSE: IFF) announced today the Total Consideration (as defined below) payable in connection with its previously announced tender offers to purchase for cash: (i) up to $1,100,000,000 aggregate purchase price, excluding accrued and unpaid interest (the “Amended Pool 1 Maximum Amount”), of its 1.230% Senior Notes due 2025 (the “2025 Notes”), 1.832% Senior Notes due 2027 (the “2027 Notes”), 4.450% Senior Notes due 2028 (the “2028 Notes”) and 2.300% Senior Notes due 2030 (the “2030 Notes” and collectively with the 2025 Notes, the 2027 Notes and the 2028 Notes, the “Pool 1 Notes”) and (ii) up to $900,000,000 aggregate purchase price, excluding accrued and unpaid interest (the “Amended Pool 2 Maximum Amount” and, together with the Amended Pool 1 Maximum Amount, the “Amended Maximum Amounts”), of its 3.268% Senior Notes due 2040 (the “2040 Notes”), 4.375% Senior Notes due 2047 (the “2047 Notes”), 5.000% Senior Notes due 2048 (the “2048 Notes”) and 3.468% Senior Notes due 2050 (the “2050

Origins Launches in the U.S. Amazon Premium Beauty Store16.5.2025 15:00:00 CEST | Press release

The brand brings its high-performance, clinically proven, nature-inspired skincare to Amazon shoppers Origins, with over 30 years of expertise in combining naturally-derived and scientifically crafted ingredients for powerful skincare, announced its official debut in the U.S. Amazon Premium Beauty store today. Origins will offer its iconic skincare and body care products along with giftable sets that are perfect for any occasion. Origins will now bring naturally-derived, effective beauty to Amazon customers nationwide with convenience and thoughtful gifting in mind. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250516435958/en/ This launch marks a strategic step in Origins’ ongoing efforts to meet the evolving needs of skincare shoppers, seeking high-performance, conscious beauty on their favorite platforms. By expanding to the U.S. Amazon Premium Beauty store, Origins reinforces its commitment to delivering both efficacy a

The smarter E Europe 2025: Studies, Technologies and Market Trends for the Energy System of Tomorrow16.5.2025 12:47:00 CEST | Press release

Exactly one week has passed since The smarter E Europe closed its doors in Munich. Once again, Europe’s largest alliance of exhibitions for the energy industry turned the Bavarian capital into the epicenter of the global energy sector and impressed with outstanding results. Over the course of three days, 2,737 exhibitors from 57 countries showcased their technologies, business models and market-ready solutions for an intelligent, interconnected and fully renewable energy system. Around 107,000 professionals from 157 nations took the opportunity to connect, initiate partnerships and launch new projects. The accompanying conferences and side events also attracted strong interest, drawing more than 2,600 participants. The message sent out by The smarter E Europe and its four exhibitions – Intersolar Europe, ees Europe, Power2Drive Europe and EM-Power Europe – was clear: We are the energy system. This press release features multimedia. View the full release here: https://www.businesswire.c

IFF Announces Early Tender Results and Increase of Tender Offers for Certain Outstanding Series of Notes16.5.2025 12:30:00 CEST | Press release

IFF (NYSE: IFF) announced today the early tender results for its tender offers to purchase for cash certain of its outstanding series of Notes. IFF also announced it has increased the previously announced Pool 1 Maximum Amount (as defined below) from $1,000,000,000 to $1,100,000,000 (the “Amended Pool 1 Maximum Amount”), the Pool 2 Maximum Amount (as defined below) from $800,000,000 to $900,000,000 (the “Amended Pool 2 Maximum Amount”, and together with the Amended Pool 1 Maximum Amount, the “Amended Maximum Amounts”), the 2027 Series Tender Cap (as defined below) from $300,000,000 to $400,000,000 and the 2050 Series Tender Cap (as defined below) from $600,000,000 to $649,114,000. The 2025 Notes Series Tender Cap and the 2040 Notes Series Tender Cap (each as defined below) remain unchanged at $500,000,000 and $450,000,000, respectively. Details of tender offers IFF initially offered to purchase for cash: (i) up to $1,000,000,000 aggregate purchase price, excluding accrued and unpaid in

I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.

Besøg vores nyhedsrum
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye